Demerol
enUKDem·er·ol
D0120500 (dĕm′ə-rôl′, -rōl′)Dem•e•rol
(ˈdɛm əˌrɔl, -ˌrɒl)Trademark.
Noun | 1. | Demerol - a synthetic narcotic drug (trade name Demerol) used to treat pain |
单词 | demerol | |||
释义 | DemerolenUKDem·er·olD0120500 (dĕm′ə-rôl′, -rōl′)Dem•e•rol(ˈdɛm əˌrɔl, -ˌrɒl)Trademark.
DemerolenUKDemerol:see analgesicanalgesic, any of a diverse group of drugs used to relieve pain. Analgesic drugs include the nonsteroidal anti-inflammatory drugs (NSAIDs) such as the salicylates, acetaminophen, narcotic drugs such as morphine, and synthetic drugs with morphinelike action such as meperidine ..... Click the link for more information. . DemerolenUKDemerol[dem´er-ol]meperidine hydrochloride (pethidine hydrochloride)Pharmacologic class: Opioid agonist Therapeutic class: Analgesic, adjunct to anesthesia Controlled substance schedule II Pregnancy risk category C ActionBinds to and depresses opiate receptors in spinal cord and CNS, altering perception of and response to pain AvailabilityInjection: 10 mg/ml, 25 mg/ml, 50 mg/ml, 75 mg/ml, 100 mg/ml Oral solution: 500 mg/5 ml Syrup: 50 mg/5 ml Tablets: 50 mg, 100 mg Indications and dosages➣ Moderate to severe pain Adults: 50 to 150 mg P.O., I.M., or subcutaneously q 3 to 4 hours as needed Children: 1.1 to 1.8 mg/kg P.O., I.M., or subcutaneously q 3 to 4 hours, not to exceed 100 mg/dose ➣ Preoperative sedation Adults: 50 to 100 mg I.M. or subcutaneously 30 to 90 minutes before anesthesia Children: 1 to 2.2 mg/kg I.M. or subcutaneously 30 to 90 minutes before anesthesia. Don't exceed adult dosage. ➣ Support of anesthesia Adults: Fractional doses (such as 10 mg/ml) by repeated slow I.V. injections or continuous I.V. infusion of a more dilute solution (such as 1 mg/ml). Dosages should be individualized. ➣ Analgesia during labor Adults: 50 to 100 mg I.M. or subcutaneously when contractions are regular. May repeat q 1 to 3 hours. Contraindications• Hypersensitivity to drug or bisulfites (with some injectable products) • MAO inhibitor use within past 14 days PrecautionsUse cautiously in: • head trauma; increased intracranial pressure (ICP); severe renal, hepatic, or pulmonary disease; hypothyroidism; adrenal insufficiency; extensive burns; alcoholism; supraventricular tachycardia; seizure disorders • undiagnosed abdominal pain or prostatic hyperplasia • elderly or debilitated patients • pregnant patients (not recommended before labor) • labor (drug may cause respiratory depression in neonate) • breastfeeding patients • children. Administration• Give I.M. injection slowly into large muscle. Preferably, use diluted solution. • Give oral solution or syrup in a half-glass of water to avoid topical anesthetic effect on mucous membranes. • Be aware that drug is compatible with 5% dextrose and lactated Ringer's solution, dextrose-saline solution combinations, and 2.5%, 5%, or 10% dextrose in water. See Know that drug is not compatible with soluble barbiturates, aminophylline, heparin, morphine sulfate, methicillin, phenytoin, sodium bicarbonate, iodide, sulfadiazine, or sulfisoxazole. • Don't give for chronic pain control, because of potential toxicity and dependence. Adverse reactionsCNS: confusion, sedation, dysphoria, euphoria, floating feeling, hallucinations, headache, unusual dreams, seizures CV: hypotension, bradycardia, cardiac arrest, shock EENT: blurred vision, diplopia, miosis GI: nausea, vomiting, constipation, ileus, biliary tract spasms GU: urinary retention Respiratory: respiratory depression, respiratory arrest Skin: flushing, sweating, induration Other: pain at injection site, local irritation, physical or psychological drug dependence, drug tolerance InteractionsDrug-drug. Antihistamines, sedative-hypnotics: additive CNS depression Barbiturates, cimetidine, protease inhibitor antiretrovirals: increased respiratory and CNS depression Chlorpromazine, thioridazine: increased risk of meperidine toxicity MAO inhibitors, procarbazine: potentially fatal reaction Opioid agonist-antagonists: precipitation of opioid withdrawal in physically dependent patients Phenytoin: increased meperidine metabolism and decreased effects Drug-diagnostic tests. Amylase, lipase: increased levels Drug-herbs. Chamomile, hops, kava, skullcap, valerian: increased CNS depression Drug-behaviors. Alcohol use: increased CNS depression Patient monitoringSee Monitor vital signs. Don't give drug if patient has significant respiratory or CNS depression. • Reassess patient's pain level after administration. See Watch for seizures, agitation, irritability, nervousness, tremors, twitches, and myoclonus in patients at risk for normeperidine accumulation (such as those with renal or hepatic impairment). See Use with extreme caution in patients with head injury. Drug may increase ICP and cause adverse reactions that obscure clinical course. • Closely monitor patients with acute abdominal pain. Drug may obscure diagnosis and clinical course of GI condition. • Evaluate bowel and bladder function. • With long-term or repeated use, watch for psychological and physical drug dependence and tolerance. See With pediatric patients, stay alert for increased risk of seizures. Patient teaching• Tell patient using oral solution or syrup to take drug with a half-glass of water to minimize local anesthetic effect. • Caution patient to avoid driving and other hazardous activities, because drug may cause dizziness or drowsiness. • Advise patient to avoid alcohol. • Instruct ambulatory patient to change position slowly to avoid orthostatic hypotension. • Tell female patient to inform prescriber if she is pregnant or breastfeeding. • As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, tests, herbs, and behaviors mentioned above. Demerol(dĕm′ə-rôl′, -rōl′)meperidineAn IV opioid analgesic with an active metabolite, normeperidine.Route Parenteral, oral. Pharmacologic effects Potent blocker of pain messages to the brain. Contraindications Co-administration with MAOI antidepressants (may cause dizziness, lightheadedness, nausea); ritonavir. T1/2 2–5 hours for relief of moderate to severe pain. Therapeutic range 200–800 ng/mL, meperidine; 130–480 ng/mL, normeperidine. Toxic range > 7 mg/L. Specimen Random urine, serum. Method Urine, TLC; serum, GC. Demerol®Meperidine, see there.DemerolA brand name for PETHIDINE (meperidine).DemerolenUK
Synonyms for Demerol
|
|||
随便看 |
|
英语词典包含2567994条英英释义在线翻译词条,基本涵盖了全部常用单词的英英翻译及用法,是英语学习的有利工具。